Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 82

1.

Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets.

Banik K, Ranaware AM, Deshpande V, Nalawade SP, Padmavathi G, Bordoloi D, Sailo BL, Shanmugam MK, Fan L, Arfuso F, Sethi G, Kunnumakkara AB.

Pharmacol Res. 2019 Apr 17;144:192-209. doi: 10.1016/j.phrs.2019.04.004. [Epub ahead of print] Review.

PMID:
31002949
2.

Cancer drug development: The missing links.

Kunnumakkara AB, Bordoloi D, Sailo BL, Roy NK, Thakur KK, Banik K, Shakibaei M, Gupta SC, Aggarwal BB.

Exp Biol Med (Maywood). 2019 May;244(8):663-689. doi: 10.1177/1535370219839163. Epub 2019 Apr 8.

PMID:
30961357
3.

Microwave-assisted synthesis of cellulose/zinc-sulfate‑calcium-phosphate (ZSCAP) nanocomposites for biomedical applications.

Dharmalingam K, Padmavathi G, Kunnumakkara AB, Anandalakshmi R.

Mater Sci Eng C Mater Biol Appl. 2019 Jul;100:535-543. doi: 10.1016/j.msec.2019.02.109. Epub 2019 Mar 12.

PMID:
30948090
4.

Induction of the Epithelial-to-Mesenchymal Transition of Human Colorectal Cancer by Human TNF-β (Lymphotoxin) and its Reversal by Resveratrol.

Buhrmann C, Yazdi M, Popper B, Kunnumakkara AB, Aggarwal BB, Shakibaei M.

Nutrients. 2019 Mar 26;11(3). pii: E704. doi: 10.3390/nu11030704.

5.

Potential of Zerumbone as an Anti-Cancer Agent.

Girisa S, Shabnam B, Monisha J, Fan L, Halim CE, Arfuso F, Ahn KS, Sethi G, Kunnumakkara AB.

Molecules. 2019 Feb 18;24(4). pii: E734. doi: 10.3390/molecules24040734. Review.

6.

Non-Curcuminoids from Turmeric and Their Potential in Cancer Therapy and Anticancer Drug Delivery Formulations.

Nair A, Amalraj A, Jacob J, Kunnumakkara AB, Gopi S.

Biomolecules. 2019 Jan 2;9(1). pii: E13. doi: 10.3390/biom9010013. Review.

7.

Potent anti-proliferative activities of organochalcogenocyanates towards breast cancer.

Banerjee K, Padmavathi G, Bhattacherjee D, Saha S, Kunnumakkara AB, Bhabak KP.

Org Biomol Chem. 2018 Nov 21;16(45):8769-8782. doi: 10.1039/c8ob01891j.

PMID:
30403243
8.

Nature-inspired development of unnatural meroterpenoids as the non-toxic anti-colon cancer agents.

Haque MA, Sailo BL, Padmavathi G, Kunnumakkara AB, Jana CK.

Eur J Med Chem. 2018 Dec 5;160:256-265. doi: 10.1016/j.ejmech.2018.08.088. Epub 2018 Aug 30.

PMID:
30368201
9.

Inflammation, a Double-Edge Sword for Cancer and Other Age-Related Diseases.

Gupta SC, Kunnumakkara AB, Aggarwal S, Aggarwal BB.

Front Immunol. 2018 Sep 27;9:2160. doi: 10.3389/fimmu.2018.02160. eCollection 2018. Review.

10.

In silico Molecular Modelling of Selected Natural Ligands and their Binding Features with Estrogen Receptor Alpha.

Maruthanila VL, Elancheran R, Roy NK, Bhattacharya A, Kunnumakkara AB, Kabilan S, Kotoky J.

Curr Comput Aided Drug Des. 2019;15(1):89-96. doi: 10.2174/1573409914666181008165356.

PMID:
30306879
11.

TIPE Family of Proteins and Its Implications in Different Chronic Diseases.

Bordoloi D, Banik K, Shabnam B, Padmavathi G, Monisha J, Arfuso F, Dharmarajan A, Mao X, Lim LHK, Wang L, Fan L, Hui KM, Kumar AP, Sethi G, Kunnumakkara AB.

Int J Mol Sci. 2018 Sep 29;19(10). pii: E2974. doi: 10.3390/ijms19102974. Review.

13.

Sorcin a Potential Molecular Target for Cancer Therapy.

Shabnam B, Padmavathi G, Banik K, Girisa S, Monisha J, Sethi G, Fan L, Wang L, Mao X, Kunnumakkara AB.

Transl Oncol. 2018 Dec;11(6):1379-1389. doi: 10.1016/j.tranon.2018.08.015. Epub 2018 Sep 11. Review.

14.

Googling the Guggul (Commiphora and Boswellia) for Prevention of Chronic Diseases.

Kunnumakkara AB, Banik K, Bordoloi D, Harsha C, Sailo BL, Padmavathi G, Roy NK, Gupta SC, Aggarwal BB.

Front Pharmacol. 2018 Aug 6;9:686. doi: 10.3389/fphar.2018.00686. eCollection 2018. Review.

15.

Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer.

Ranaware AM, Banik K, Deshpande V, Padmavathi G, Roy NK, Sethi G, Fan L, Kumar AP, Kunnumakkara AB.

Int J Mol Sci. 2018 Aug 10;19(8). pii: E2362. doi: 10.3390/ijms19082362. Review.

16.

NGAL is Downregulated in Oral Squamous Cell Carcinoma and Leads to Increased Survival, Proliferation, Migration and Chemoresistance.

Monisha J, Roy NK, Padmavathi G, Banik K, Bordoloi D, Khwairakpam AD, Arfuso F, Chinnathambi A, Alahmadi TA, Alharbi SA, Sethi G, Kumar AP, Kunnumakkara AB.

Cancers (Basel). 2018 Jul 10;10(7). pii: E228. doi: 10.3390/cancers10070228.

17.

Novel tumor necrosis factor-α induced protein eight (TNFAIP8/TIPE) family: Functions and downstream targets involved in cancer progression.

Padmavathi G, Banik K, Monisha J, Bordoloi D, Shabnam B, Arfuso F, Sethi G, Fan L, Kunnumakkara AB.

Cancer Lett. 2018 Sep 28;432:260-271. doi: 10.1016/j.canlet.2018.06.017. Epub 2018 Jun 18.

PMID:
29920292
18.

Possible use of Punica granatum (Pomegranate) in cancer therapy.

Khwairakpam AD, Bordoloi D, Thakur KK, Monisha J, Arfuso F, Sethi G, Mishra S, Kumar AP, Kunnumakkara AB.

Pharmacol Res. 2018 Jul;133:53-64. doi: 10.1016/j.phrs.2018.04.021. Epub 2018 May 2. Review.

PMID:
29729421
19.

Novel AKT1 mutations associated with cell-cycle abnormalities in gastric carcinoma.

Ghatak S, Lalnunhlimi S, Lalrohlui F, Pautu JL, Zohmingthanga J, Kunnumakkara AB, Kumar NS.

Per Med. 2018 Mar;15(2):79-86. doi: 10.2217/pme-2017-0053. Epub 2018 Jan 30.

PMID:
29714127
20.

Tocotrienols: The promising analogues of vitamin E for cancer therapeutics.

Sailo BL, Banik K, Padmavathi G, Javadi M, Bordoloi D, Kunnumakkara AB.

Pharmacol Res. 2018 Apr;130:259-272. doi: 10.1016/j.phrs.2018.02.017. Epub 2018 Feb 27. Review.

PMID:
29496592

Supplemental Content

Loading ...
Support Center